AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Edwards Lifesciences Corp... (EW)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

75.57

-0.62 (-0.81%)

At close: Feb 18, 2025, 3:59 PM

75.67

0.13%

After-hours: Feb 18, 2025, 07:00 PM EST

undefined% (undefined)

Bid	74.74
Market Cap	44.57B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	2.34
PE Ratio (ttm)	32.29
Forward PE	n/a
Analyst	Hold

Ask	77.6
Volume	3,172,996
Avg. Volume (20D)	4,779,277
Open	75.86
Previous Close	76.19
Day's Range	75.56 - 76.67
52-Week Range	58.93 - 96.12
Beta	undefined

About EW

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the P...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Mar 27, 2000

Employees 16,000

Stock Exchange NYSE

Ticker Symbol EW

Website https://www.edwards.com

Full Company Profile

Analyst Forecast

According to 21 analyst ratings, the average rating for EW stock is "Hold." The 12-month stock price forecast is $78, which is an increase of 3.22% from the latest price.

Buy 47.62%

Hold 47.62%

Sell 4.76%

Stock Forecasts

Next Earnings Release

Edwards Lifesciences Corporation is scheduled to release its earnings on Apr 24, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

6 days ago

+6.92%

Edwards Lifesciences shares are trading higher aft... Unlock content with Pro Subscription

1 week ago

+6.92%

Edwards Lifesciences shares are trading higher following a Q4 earnings beat.

News

1 week ago · benzinga.com

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

On Tuesday, Edwards Lifesciences EW reported fourth-quarter sales of $1.39 billion, beating the consensus of $1.36 billion. This represents a 9% year-over-year growth, supported by gains in all produc...

6 days ago · zacks.com

EW Stock Up on Q4 Earnings and Revenue Beat, Margins Crash

Edwards Lifesciences reports strong contributions from all product groups ??? TAVR, TTMT and surgical structural heart?

1 week ago · seekingalpha.com

Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript

Edwards Lifesciences Corporation (NYSE:EW ) Q4 2024 Earnings Conference Call February 11, 2025 5:00 PM ET Company Participants Mark Wilterding - Senior Vice President, Investor Relations Bernard Zovig...

1 week ago · zacks.com

Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare wit...

1 week ago · reuters.com

Edwards Lifesciences beats profit estimate on strength in heart devices

Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.

1 week ago · businesswire.com

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to $1.39 bi...

1 week ago · zacks.com

Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared du...

2 weeks ago · zacks.com

ITGR or EW: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to va...

2 weeks ago · businesswire.com

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2024 after the market closes on Tuesday February 11, 2025, a...

2 weeks ago · benzinga.com

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Edwards Lifesciences Corporation EW shares are trading higher on Thursday.

Load More News